Unidad de Citogenética Molecular

Inicio | Investigación e innovación | Programas Científicos | Programa de Genética del Cáncer Humano | Unidad de Citogenética Molecular

Sandra Rodríguez
Sandra Rodríguez Jefe de Unidad
T +34 917328000 (Ext 3340)

Investigadores Científicos

  • Raúl Torres

Becarios Pre-Doctorales

  • Alejandro Alonso
  • Alejandro Nieto
  • Pilar Puig

Técnicos de Laboratorio

  • M. Carmen Martín
  • Christian Moreno
  • Francisco José Moya

Recurrent chromosomal rearrangements, changes in the structure of native chromosomes, are very common and well-known hallmarks of cancer. A better understanding of these cancer-causing mechanisms will lead to novel therapeutic regimens to fight cancer. The research activity of the Molecular Cytogenetics and Genome Editing Unit focuses on increasing our knowledge about the role of chromosomal rearrangements in cancer development and progression and discovering new therapeutic targets. With the combined use of CRISPR genome editing and cytogenetic technologies, we are creating models that recapitulate chromosomal and genetic cancer alterations. The goal of the Unit is to provide CNIO and external researchers with the latest technologies used in the fields of molecular cytogenetics and genome editing. The Unit is continuously implementing and developing new technologies in those fields. We also participate in collaborative projects with clinical and basic science investigators across the CNIO and other institutions.